Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.

[1]  J. Nanubolu,et al.  One-pot, three-component approach to the synthesis of 3,4,5-trisubstituted pyrazoles. , 2015, The Journal of organic chemistry.

[2]  J. Nanubolu,et al.  Diastereoselective synthesis of spiro[cyclopropane-1,3′-indolin]-2′-ones through metal-free cyclopropanation using tosylhydrazone salts , 2014 .

[3]  J. Nanubolu,et al.  Highly Diastereoselective Synthesis of Spiro[cyclopropane-1,3′-indolin]-2′-ones via Catalyst-Free Cyclopropanation Using Ethyl Diazoacetate. , 2014 .

[4]  D. Fan,et al.  Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. , 2014, Cancer letters.

[5]  A. Thorburn,et al.  Autophagy and Cancer Therapy , 2014, Molecular Pharmacology.

[6]  K. Arya,et al.  Design, synthesis and biological evaluation of novel spiro[indole-pyridothiazine] analogs as antiproliferative agents , 2014 .

[7]  Shaobin Li,et al.  Synthesis, structure-activity relationship and biological activity of acridine derivatives as potent MDR-reversing agents. , 2013, Current medicinal chemistry.

[8]  A. Kamal,et al.  Catalyst-free stereoselective cyclopropanation of electron deficient alkenes with ethyl diazoacetate , 2013 .

[9]  Hong‐yu Li,et al.  Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators. , 2013, Journal of medicinal chemistry.

[10]  E. Novellino,et al.  Synthesis, in vitro, and in cell studies of a new series of [indoline-3,2'-thiazolidine]-based p53 modulators. , 2013, Journal of medicinal chemistry.

[11]  R. Lesyk,et al.  Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. , 2012, Journal of medicinal chemistry.

[12]  M. Marques,et al.  New strategies against prostate cancer--Pt(II)-based chemotherapy. , 2012, Current medicinal chemistry.

[13]  G. Gasser,et al.  Organometallic Anticancer Compounds , 2010, Journal of medicinal chemistry.

[14]  E. Novellino,et al.  Identification of the spiro(oxindole-3,3'-thiazolidine)-based derivatives as potential p53 activity modulators. , 2010, Journal of medicinal chemistry.

[15]  Maria Paola Costi,et al.  Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs. , 2010, Journal of medicinal chemistry.

[16]  F. Meng,et al.  Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. , 2010, Cancer letters.

[17]  Qiaojun He,et al.  Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells , 2010, Investigational New Drugs.

[18]  Atul Kumar,et al.  Diversity oriented synthesis of benzoxanthene and benzochromene libraries via one-pot, three-component reactions and their anti-proliferative activity. , 2010, Journal of combinatorial chemistry.

[19]  N. Mahindroo,et al.  Hedgehog-Gli signaling pathway inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.

[20]  J. Pollard,et al.  Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.

[21]  Min Yang,et al.  Casticin induces leukemic cell death through apoptosis and mitotic catastrophe , 2009, Annals of Hematology.

[22]  A. Kurimasa,et al.  Synthetic retinoid CD437 induces mitochondria-mediated apoptosis in hepatocellular carcinoma cells. , 2008, Biochemical and biophysical research communications.

[23]  B. Skelton,et al.  Synthesis of novel 3'-spirocyclic-oxindole derivatives and assessment of their cytostatic activities , 2007 .

[24]  M. Botta,et al.  Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J. , 2007, Bioorganic & medicinal chemistry letters.

[25]  Sharad Kumar,et al.  Caspase function in programmed cell death , 2007, Cell Death and Differentiation.

[26]  Lei Wu,et al.  The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity. , 2006, Cancer research.

[27]  J. Snyder,et al.  Microtubule-interacting drugs for cancer treatment. , 2003, Trends in pharmacological sciences.

[28]  T. Fojo,et al.  Tubulin/microtubules: still a promising target for new chemotherapeutic agents. , 2000, Journal of the National Cancer Institute.

[29]  N. Lawrence,et al.  Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle , 1998, Medicinal research reviews.

[30]  N. Thornberry.  Caspases: key mediators of apoptosis. , 1998, Chemistry & biology.

[31]  Z. Darżynkiewicz,et al.  Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. , 1994, Cytometry.

[32]  G. Faita,et al.  An easy lewis acid-mediated isomerization from (E)- to (Z)-Oxoindolin-3-ylidene ketones. , 1994 .